Tradestie Institutional Equity Comparison Engine
XNCR vs BOLD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
XNCR Overall Edge
XNCR Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xencor, Inc. (XNCR) driven by superior Valuation, Momentum & Technical, Options & Structure while BOLD counters with relative strength in Growth & Margin. Fundamentally, XNCR trades at 68.0x Forward P/E with -72.7% operating margin (+454.9% YoY revenue) versus BOLD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, XNCR sits in BREAKOUT (11th %ile IV; Dealer Gamma Walls on Pro) against BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
XNCR
XNCR 68.0x vs BOLD N/M Fwd P/E
Growth & Margin Winner
BOLD
Op Margin -72.7% vs 0.0% ยท YoY +454.9% vs +0.0%
Momentum & Technical Winner
XNCR
1Y +110.9% vs +101.7% ยท 52W Pos 76% vs 62%
Options & Structure Winner
XNCR
BREAKOUT (11th %ile IV) vs UNCLASSIFIED (N/A IV)
XNCR
NASDAQ
Xencor, Inc.
Pharmaceutical Preparations
$33.26
-2.21% 1D
Market Cap
$2.6B
1M Return
+28.72%
1Y Return
+110.91%
Forward P/E
68.0x
Unified AI Score
36.3 / 100
SELL
Tech 15.0
Fund 42.0
Flow 68.0
Mom 50.0
BOLD
NASDAQ
Boundless Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.32
-2.52% 1D
Market Cap
$56.2M
1M Return
-4.92%
1Y Return
+101.74%
Forward P/E
N/M
Unified AI Score
36.8 / 100
SELL
Tech 25.0
Fund 50.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XNCR +110.91%
BOLD +101.74%
Spread: +9.17 pp (XNCR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XNCR TTM Op. Margin: -72.7%
BOLD TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XNCR vs BOLD. Trailing 12-month operating profitability (XNCR -72.7% vs BOLD 0.0%) and valuation multiples (XNCR 68.0x vs BOLD N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XNCR | BOLD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.6B | $56.2M | Larger Scale | XNCR |
| Trailing P/E Ratio Valuation | 68.0x | N/M | Lower Multiple | XNCR |
| Forward P/E Ratio Valuation | 68.0x | N/M | Lower Multiple | XNCR |
| Revenue Growth (YoY) Growth | +454.9% | +0.0% | Higher Growth | XNCR |
| Operating Margin (TTM) Profitability | -72.7% | 0.0% | Higher Margin | BOLD |
| Net Profit Margin Profitability | -58.8% | 0.0% | Higher Margin | BOLD |
| Return on Equity (ROE) Capital Efficiency | -19.9% | -64.6% | Higher ROE | XNCR |
| 52-Week Range Position Momentum | 76% ($10โ$41) | 62% ($1โ$3) | Stronger Trend | XNCR |
| Beta / 30D Volatility Risk Regime | 1.18ฮฒ ยท 86% Vol | -0.08ฮฒ ยท 28% Vol | Lower Realized Risk | BOLD |
| Unified Institutional Score Composite Signal | 36.3 / 100 (SELL) | 36.8 / 100 (SELL) | Higher Composite | BOLD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XNCR vs BOLD Buy Guide
XNCR
BREAKOUT
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
11th %ile
IV Regime
Compressed (<25th %ile)
BOLD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XNCR nor BOLD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.